Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1999 Dec;44(12):2397-404.
doi: 10.1023/a:1026662316750.

Potential relevance of agmatine as a virulence factor of Helicobacter pylori

Affiliations

Potential relevance of agmatine as a virulence factor of Helicobacter pylori

G J Molderings et al. Dig Dis Sci. 1999 Dec.

Abstract

The polyamine agmatine is able to increase gastric acid secretion. Therefore, we investigated whether Helicobacter pylori is able to form and release agmatine in vitro and in the human stomach in vivo, and if so, whether a relationship exists among agmatine concentration in gastric juice, H. pylori infection, and gastroduodenal lesions. Agmatine was determined by means of HPLC. In the supernatant of H. pylori cultures, agmatine concentrations up to 1500 ng/ml (approximately 12 microM) were determined, depending on the number of the bacteria in the individual cultures. Agmatine concentration in gastric juice from H. pylori-positive patients was higher than in that from H. pylori-negative patients. Gastrin in blood was elevated in H. pylori-positive patients compared with H. pylori-negative patients. Agmatine concentration in gastric juice and serum gastrin level appeared to be related. In conclusion, H. pylori is able to form and to release agmatine in vitro and in vivo. This may be assumed to be relevant in vivo, since higher amounts of agmatine are present in gastric juice from H. pylori-positive than from H. pylori-negative patients. Accordingly, agmatine produced by H. pylori may be a virulence factor of this bacterium and may be involved in the pathogenesis of gastroduodenal lesions.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Pharmacol Exp Ther. 1998 Apr;285(1):170-7 - PubMed
    1. Gastroenterology. 1995 Sep;109(3):681-91 - PubMed
    1. Proc Natl Acad Sci U S A. 1987 Jul;84(13):4423-7 - PubMed
    1. J Biol Chem. 1994 Apr 8;269(14):10566-73 - PubMed
    1. Aliment Pharmacol Ther. 1996 Apr;10 Suppl 1:97-102 - PubMed

Publication types

LinkOut - more resources